The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Benzodiazepines: Risks and benefits. A reconsideration
Open accessAbstract
Over the last decade there have been further developments in our knowledge of the risks and benefits of benzodiazepines, and of the risks and benefits of alternatives to benzodiazepines. Representatives drawn from the Psychopharmacology Special Interest Group of the Royal College of Psychiatrists and the British Association for Psychopharmacology together examined these developments, and have provided this joint statement with recommendations for clinical practice. The working group was mindful of widespread concerns about benzodiazepines and related anxiolytic and hypnotic drugs. The group believes that whenever benzodiazepines are prescribed, the potential for dependence or other harmful effects must be considered. However, the group also believes that the risks of dependence associated with long-term use should be balanced against the benefits that in many cases follow from the short or intermittent use of benzodiazepines and the risk of the underlying conditions for which treatment is being provided.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They have been shown to be effective in the acute treatment of generalized anxiety disorder, social anxiety, panic disorder, and insomnia [8].”
Citations
Cites
Wilson, S., Nutt, D., Alford, C., Argyropoulos, S., Baldwin, D., Bateson, A., Britton, T., Crowe, C., Dijk, D.-J., Espie, C., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110379307 · Cited by 634
Self-citationBaldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T., den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J., et al. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105059253 · Cited by 617
Self-citationLingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444324 · Cited by 332
Self-citationDell’osso, B., & Lader, M. (2013) · European Psychiatry · doi:10.1016/j.eurpsy.2011.11.003 · Cited by 210
Uncritical positive regard? Issues in the efficacy and safety of psychotherapy
Nutt, D. J., & Sharpe, M. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107086283 · Cited by 123
Self-citationSubstitution therapy for alcoholism: time for a reappraisal?
Chick, J., & Nutt, D. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111408463 · Cited by 80
Self-citationNeuropharmacology of Benzodiazepines
Stephens, D., & King, S. L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-398335-0.00059-5 · Cited by 2
Self-citation
Cited by
Sorted by citations
Treatment of Benzodiazepine Dependence
Soyka, M. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1611832 · Cited by 465
Kurko, T., Saastamoinen, L., Tähkäpää, S.-M., Tuulio‐Henriksson, A., Taiminen, T. J., Tiihonen, J., Airaksinen, M., & Hietala, J. A. (2015) · European Psychiatry · doi:10.1016/j.eurpsy.2015.09.003 · Cited by 283
Rogers, J. P., Oldham, C. M., Fricchione, G. L., Northoff, G., Wilson, J. E., Mann, S. C., Francis, A., Wieck, A., Wachtel, L. E., Lewis, G., et al. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231158232 · Cited by 277
Self-citationPolypharmacy Management in Older Patients
Hoel, R. W., Connolly, R. M. G., & Takahashi, P. Y. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.06.012 · Cited by 235
Sequential drug treatment algorithm for agitation and aggression in Alzheimer’s and mixed dementia
Davies, S., Burhan, A. M., Kim, D., Gerretsen, P., Graff‐Guerrero, A., Woo, V. L., Kumar, S., Colman, S., Pollock, B. G., Mulsant, B. H., et al. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117744996 · Cited by 150
Self-citation
Metadata
- Authors
- Baldwin, D. S., Aitchison, K., Bateson, A., Curran, H. V., Davies, S., Leonard, B., Nutt, D. J., Stephens, D. N., & Wilson, S.
- Affiliations
- University of Southampton (GB)
- University of Alberta (CA)
- Ross University School of Medicine (BB)
- University College London (GB)
- Centre for Addiction and Mental Health (CA)
- Ollscoil na Gaillimhe – University of Galway (IE)
- Imperial College London (GB)
- University of Sussex (GB)
- Corresponding author
- Baldwin, David S
- ORCID
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2013-09-24
- Volume
- 27
- Issue
- 11
- Pages
- 967-971
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2116273170
- Cited by
- 249
- References
- 7
- Citations by year
- 2026: 17 · 2025: 19 · 2024: 14 · 2023: 21 · 2022: 21 · 2021: 22 · 2020: 23 · 2019: 21 · 2018: 21 · 2017: 19 · 2016: 19 · 2015: 16 · 2014: 15
- FWCI
- 22.52
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Research Bank (Australian Catholic University) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- benzodiazepines, anxiolytics, hypnotics, benzodiazepine dependence, long-term benzodiazepine use, benefits and risks, clinical guidelines, anxiety disorders, insomnia
- MeSH terms
- Benzodiazepines, Humans, Hypnotics and Sedatives, Practice Guidelines as Topic, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
